NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Provista Diagnostics today announced the closing of a financing round bringing in $6 million. 

Funding from the Series A-2 Preferred financing round came from existing investors exercising warrants from a previous financing round, the New York-based company said, adding that proceeds will be used for continued commercial development, prospective clinical trials, key management hires, and general corporate purposes. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.